New delivery system targets rapid-onset relief for motion sickness and vertigo, modernizing the $450M global market for the ...
A Consumer Information Guide to Nail Refresh's Tea Tree Oil, Oregano Oil, and Multi-Botanical Essential Oil Blend for Topical Toenail Care ...
Yet, importantly, Medicare beneficiaries aren’t covered when services are provided by pharmacists. These policies leave ...
Wall Street analysts are placing aggressive bets on four clinical-stage biotech companies, with consensus price targets ...
Ocular Therapeutix reported a phase 3 win that it believes can validate its attempts to challenge Regeneron’s entrenched ...
Canada's health regulator has approved Merck's new under-the-skin version of its cancer drug Keytruda, offering an alternative to the current intravenous infusion. Health Canada has approved Keytruda ...
NRx together with Osmind, Inc. conducted an in-person meeting attended by leadership of the FDA Division of Psychiatry ...
Results from the phase 2b PROCEED trial of intravenous bocunebart (also known as Lu AG09222) showed that the drug was able to ...
In response to last month’s list of the 15 drugs chosen by the Centers for Medicare & Medicaid Services (CMS) for upcoming ...
Pharmaceutical companies follow strict quality standards, and if a drug’s stability falters at any point – whether during development, storage, or shipping, it can undo all the work that’s gone into ...
In an interview with Technology Networks, Dr. Daniel Reker discusses how machine learning is improving data-scarce areas of ...
New delivery system targets rapid-onset relief for motion sickness and vertigo, modernizing the $450M global market for the active ingredient in Dramamine.Meclizine was the top-prescribed antiemetic/a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results